AI
Friday, November 17, 2017 9:50:20 AM
2 Stocks Remain Some Of The Top Stocks To Watch: Aurinia Pharmaceuticals Inc. (AUPH), Castle Brands Inc. (NYSEAmerican:ROX)
November 17, 2017
Pete Parker
(Is this Spiderman
It's nice to see ROX getting "ink".
http://thewellesleysnews.com/2017/11/17/2-stocks-remain-some-of-the-top-stocks-to-watch-aurinia-pharmaceuticals-inc-auph-castle-brands-inc-nyseamericanrox/
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) shares ended at $5.19 with 0.96 mln shares exchanging hands. That puts the market capitalization at $0 mln. It opened the session with a $5.03 price tag, later ranging from $5.03 to $5.25, the range at which the stock has traded at throughout the day. The stock stands nearly -50.76% off versus the 52-week high and 156.93% away from the 52-week low. The number of shares currently owned by investors are 0 mln.
Sell-side analyst recommendations point to a short term price target of $15.23 on the shares of Aurinia Pharmaceuticals Inc. (AUPH). The consensus rating is 1.7, indicating analysts in general look favorably on the company’s future prospects. It has been assigned a low target price of $12.67 and a high target price of $17.87.
The current price is staying below the SMA lines which signify weakens and is generally unhealthy/negative and may provide the momentum for driving the share price lower. Current price places the company’s stock -17.23% away from its 200-day simple moving average, -15.97%, away from the 50-day average and also -9.95% away from 20-day average.
For this year, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is performing 147.14%. Over the past five trading sessions it is -9.27%; -20.28% for the month; -14.92% for the last quarter; -27.62% for the past six-months; and 28.15% for the last 12 months. The last close places the company’s stock about $5.35 off its 52 week high of $10.54 and $3.17 above the 52 week low of $2.02.
Castle Brands Inc. (NYSEAmerican:ROX) closed up +0.04 points or 3.74% at $1.11 with 0.49 mln shares exchanging hands. Current price level places the company’s stock about -50% from the 52-week high and 70.77% away from the 52-week low. Sell-side analyst recommendations point to a short term price target of $2 on the company shares. The consensus rating is 1, indicating analysts in general look favorably on the company’s future prospects. It has been assigned a low target price of $2 and a high target price of $2.
Castle Brands Inc. (ROX) opened the session with a $1.06 price tag, later ranging from $1.06 to $1.14, the range at which the stock has traded at throughout the day. The stock stands nearly $1.16 off versus the 52-week high of $2.22 and $0.41 above the 52-week low of $0.65. The number of shares currently owned by investors are 173.15 mln. The current price change puts the market capitalization at $192.2 mln.
In an overview of the current analyst recommendations, Buy count is 1 and Overweight is 0 while the number of analysts recommending Sell and Underweight are 0 and 0, respectively. Also, the Hold rating count is 0 as of 11/16/17. The analyst recommendations from a month ago are 1 Buy, 0 Overweight, 0 Sell, 0 Hold and 0 Underweight. Investors might also notice that three month ago the Buy recommendations (1) outnumbered Sell recommendations (0). The count of Hold ratings in that period was 0.
November 17, 2017
Pete Parker
(Is this Spiderman
It's nice to see ROX getting "ink". http://thewellesleysnews.com/2017/11/17/2-stocks-remain-some-of-the-top-stocks-to-watch-aurinia-pharmaceuticals-inc-auph-castle-brands-inc-nyseamericanrox/
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) shares ended at $5.19 with 0.96 mln shares exchanging hands. That puts the market capitalization at $0 mln. It opened the session with a $5.03 price tag, later ranging from $5.03 to $5.25, the range at which the stock has traded at throughout the day. The stock stands nearly -50.76% off versus the 52-week high and 156.93% away from the 52-week low. The number of shares currently owned by investors are 0 mln.
Sell-side analyst recommendations point to a short term price target of $15.23 on the shares of Aurinia Pharmaceuticals Inc. (AUPH). The consensus rating is 1.7, indicating analysts in general look favorably on the company’s future prospects. It has been assigned a low target price of $12.67 and a high target price of $17.87.
The current price is staying below the SMA lines which signify weakens and is generally unhealthy/negative and may provide the momentum for driving the share price lower. Current price places the company’s stock -17.23% away from its 200-day simple moving average, -15.97%, away from the 50-day average and also -9.95% away from 20-day average.
For this year, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is performing 147.14%. Over the past five trading sessions it is -9.27%; -20.28% for the month; -14.92% for the last quarter; -27.62% for the past six-months; and 28.15% for the last 12 months. The last close places the company’s stock about $5.35 off its 52 week high of $10.54 and $3.17 above the 52 week low of $2.02.
Castle Brands Inc. (NYSEAmerican:ROX) closed up +0.04 points or 3.74% at $1.11 with 0.49 mln shares exchanging hands. Current price level places the company’s stock about -50% from the 52-week high and 70.77% away from the 52-week low. Sell-side analyst recommendations point to a short term price target of $2 on the company shares. The consensus rating is 1, indicating analysts in general look favorably on the company’s future prospects. It has been assigned a low target price of $2 and a high target price of $2.
Castle Brands Inc. (ROX) opened the session with a $1.06 price tag, later ranging from $1.06 to $1.14, the range at which the stock has traded at throughout the day. The stock stands nearly $1.16 off versus the 52-week high of $2.22 and $0.41 above the 52-week low of $0.65. The number of shares currently owned by investors are 173.15 mln. The current price change puts the market capitalization at $192.2 mln.
In an overview of the current analyst recommendations, Buy count is 1 and Overweight is 0 while the number of analysts recommending Sell and Underweight are 0 and 0, respectively. Also, the Hold rating count is 0 as of 11/16/17. The analyst recommendations from a month ago are 1 Buy, 0 Overweight, 0 Sell, 0 Hold and 0 Underweight. Investors might also notice that three month ago the Buy recommendations (1) outnumbered Sell recommendations (0). The count of Hold ratings in that period was 0.
